J. John and M. , Kelso -Division of Allergy, Asthma, and Immunology, Scripps Clinic, 3811 Valley Centre Drive

I. Equipe and E. , Reported no conflict of interest Reported no conflict of interest CP: Claude Ponvert -Department Paediatrics, Pulmonology and Allergy service, Necker-Enfants Malades Hospital, 149 rue de Sèvres, 75015 Paris (France). claude.ponvert@orange.fr. Reported no conflict of interest. PD: Pascal Demoly -Département de Pneumologie et Addictologie sanchezbmario@gmail.com. Reported no conflict of interest. AM: Antonella Muraro -Food Allergy Referral Centre Dept of Women and Child health muraro@centroallergiealimentari.eu. Reported no conflict of interest, Montpellier cedex 05 ? FRANCE and Sorbonne Universités pascal.demoly@inserm.fr. Reported no conflict of interest. MSB: Mario Sanchez Borges -Centro Médico-Docente JL: James T. Li -Division of Allergic Diseases, Mayo Clinic, Rochester MN 55905 USA. li.james@mayo.edu. Reported no conflict of interest. MR: Menachem Rottem -Allergy Asthma and Immunology, Emek Medical Center, Afula, and the Rappaport Faculty of Medicine

U. , I. , I. Equipe, and E. , 12 Allergy and Clinical Immunology Department 13 Food Allergy Referral Centre Department of Women and Child health 14 Division of Allergic Diseases, 15 Allergy Asthma and Immunology, Emek Medical Center, Afula, and the Rappaport Faculty of Medicine, p.16

I. Delany, R. Rappuoli, D. Gregorio, and E. , Vaccines for the 21st century, EMBO Molecular Medicine, vol.6, issue.6, pp.708-728, 2014.
DOI : 10.1002/emmm.201403876

C. Whitney, F. Zhou, J. Singleton, and A. Schuchat, Benefits from immunization during the vaccines for children program era -United States, 1994.

J. Caubet and C. Ponvert, Vaccine Allergy, Immunology and Allergy Clinics of North America, vol.34, issue.3, pp.597-613, 2014.
DOI : 10.1016/j.iac.2014.04.004

J. Kelso, M. Greenhawt, J. Li, R. Nicklas, D. Bernstein et al., Adverse reactions to vaccines practice parameter 2012 update, Journal of Allergy and Clinical Immunology, vol.130, issue.1, pp.25-43, 2012.
DOI : 10.1016/j.jaci.2012.04.003

A. Vanlander and K. Hoppenbrouwers, Anaphylaxis after vaccination of children: Review of literature and recommendations for vaccination in child and school health services in Belgium, Vaccine, vol.32, issue.26, pp.3147-54, 2014.
DOI : 10.1016/j.vaccine.2014.03.096

R. Wood, Allergic reactions to vaccines, Pediatric Allergy and Immunology, vol.41, issue.6, pp.521-527, 2013.
DOI : 10.1111/pai.12102
URL : https://hal.archives-ouvertes.fr/inserm-01367834

K. Bohlke, R. Davis, S. Marcy, M. Braun, F. Destefano et al., Risk of Anaphylaxis After Vaccination of Children and Adolescents, PEDIATRICS, vol.112, issue.4, pp.815-835, 2003.
DOI : 10.1542/peds.112.4.815

O. Zent, C. Arras-reiter, M. Broeker, and R. Hennig, Immediate allergic reactions after vaccinations ??? a post-marketing surveillance review, European Journal of Pediatrics, vol.161, issue.1, pp.21-26, 2002.
DOI : 10.1007/s00431-001-0853-0

M. Erlewyn-lajeunesse, L. Hunt, P. Heath, and A. Finn, Anaphylaxis as an adverse event following immunisation in the UK and Ireland, Archives of Disease in Childhood, vol.97, issue.6, pp.487-90, 2012.
DOI : 10.1136/archdischild-2011-301163

D. Cheng, K. Perrett, S. Choo, M. Danchin, J. Buttery et al., Pediatric anaphylactic adverse events following immunization in Victoria, Australia from 2007 to 2013, Vaccine, vol.33, issue.13, pp.1602-1609, 2007.
DOI : 10.1016/j.vaccine.2015.02.008

J. Lotvall, R. Pawankar, D. Wallace, C. Akdis, L. Rosenwasser et al., We Call for iCAALL, World Allergy Organization Journal, vol.5, issue.3, pp.215-221, 2012.
DOI : 10.1097/WOX.0b013e3182504245

J. Lotvall, R. Pawankar, D. Wallace, C. Akdis, L. Rosenwasser et al., We Call for iCAALL, World Allergy Organization Journal, vol.5, issue.3, 2012.
DOI : 10.1097/WOX.0b013e3182504245

J. Lotvall, R. Pawankar, D. Wallace, C. Akdis, L. Rosenwasser et al., We Call for iCAALL, World Allergy Organization Journal, vol.5, issue.3, pp.449-50, 2012.
DOI : 10.1097/WOX.0b013e3182504245

J. Lotvall, R. Pawankar, D. Wallace, C. Akdis, L. Rosenwasser et al., We Call for iCAALL, World Allergy Organization Journal, vol.5, issue.3, pp.39-40, 2012.
DOI : 10.1097/WOX.0b013e3182504245

A. Kroger, C. Sumaya, L. Pickering, and W. Atkinson, General recommendations on immunization, MMWR Recomm Rep, vol.60, issue.2, pp.1-64, 2011.

S. Johansson, J. Hourihane, J. Bousquet, C. Bruijnzeel-koomen, S. Dreborg et al., A revised nomenclature for allergy: An EAACI position statement from the EAACI nomenclature task force, Allergy, vol.55, issue.9, pp.813-837, 2001.
DOI : 10.1034/j.1398-9995.2000.00115.x

F. Simons, L. Ardusso, M. Bilo, V. Cardona, M. Ebisawa et al., International consensus on (ICON) anaphylaxis, World Allergy Organization Journal, vol.7, issue.1, pp.9-10, 2014.
DOI : 10.1542/peds.2007-1395

H. Sampson, A. Munoz-furlong, R. Campbell, A. Jr, N. Bock et al., Second symposium on the definition and management of anaphylaxis: Summary report???Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium, Journal of Allergy and Clinical Immunology, vol.117, issue.2, pp.391-398, 2006.
DOI : 10.1016/j.jaci.2005.12.1303

J. Ruggeberg, M. Gold, J. Bayas, M. Blum, J. Bonhoeffer et al., Anaphylaxis: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data, Vaccine, vol.25, issue.31, pp.5675-84, 2007.
DOI : 10.1016/j.vaccine.2007.02.064

F. Simons and H. Sampson, Anaphylaxis: Unique aspects of clinical diagnosis and management in infants (birth to age 2 years), Journal of Allergy and Clinical Immunology, vol.135, issue.5, pp.1125-1156, 2015.
DOI : 10.1016/j.jaci.2014.09.014

F. Simons and H. Sampson, Anaphylaxis epidemic: Fact or fiction?, Journal of Allergy and Clinical Immunology, vol.122, issue.6, pp.1166-1174, 2008.
DOI : 10.1016/j.jaci.2008.10.019

F. Simons, Anaphylaxis pathogenesis and treatment, Allergy, vol.122, pp.31-35, 2011.
DOI : 10.1111/j.1398-9995.2011.02629.x

J. Lee and D. Greenes, Biphasic Anaphylactic Reactions in Pediatrics, PEDIATRICS, vol.106, issue.4, pp.762-768, 2000.
DOI : 10.1542/peds.106.4.762

P. Lieberman, Biphasic anaphylactic reactions, Annals of Allergy, Asthma & Immunology, vol.95, issue.3, pp.217-243, 2005.
DOI : 10.1016/S1081-1206(10)61217-3

R. Vinuya, M. Simon, and L. Schwartz, Elevated serum tryptase levels in a patient with protracted anaphylaxis, Ann Allergy, vol.73, issue.3, pp.232-236, 1994.

A. Muraro, G. Roberts, M. Worm, M. Bilo, K. Brockow et al., Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology, Allergy, vol.2, issue.8, pp.1026-1071, 2014.
DOI : 10.1111/all.12437

R. Pumphrey, Lessons for management of anaphylaxis from a study of fatal reactions, Clinical <html_ent glyph="@amp;" ascii="&"/> Experimental Allergy, vol.96, issue.4, pp.1144-50, 2000.
DOI : 10.1016/0895-4356(94)00235-I

P. Lieberman, R. Nicklas, J. Oppenheimer, S. Kemp, D. Lang et al., The diagnosis and management of anaphylaxis: An updated practice parameter, Journal of Allergy and Clinical Immunology, vol.115, issue.3, p.2010
DOI : 10.1016/j.jaci.2005.01.010

A. Cheifetz, M. Smedley, S. Martin, M. Reiter, G. Leone et al., The incidence and management of infusion reactions to infliximab: a large center experience, The American Journal of Gastroenterology, vol.134, issue.6, pp.1315-1339, 2003.
DOI : 10.1016/S0140-6736(02)08512-4

S. Brown, S. Kemp, P. Lieberman, and . Anaphylaxis, Middleton's Allergy: Principles and Practice, Philadelphia, pp.1237-59, 2014.

M. Buettcher, U. Heininger, M. Braun, J. Bonhoeffer, S. Halperin et al., Hypotonic-hyporesponsive episode (HHE) as an adverse event following immunization in early childhood: Case definition and guidelines for data collection, analysis, and presentation, Vaccine, vol.25, issue.31, pp.5875-81, 2007.
DOI : 10.1016/j.vaccine.2007.04.061

C. Centers-for-disease and . Prevention, Syncope after vaccination?United States, MMWR Morb Mortal Wkly Rep, vol.57, issue.17, pp.457-60, 2005.

D. Sood, S. Kumar, S. Singh, and J. Sokhey, Adverse reactions after measles vaccination in India, Natl Med J India, vol.8, issue.5, pp.208-218, 1995.

P. Orr, Supplementary statement for the 2002?2003 influenza season: update on oculo-respiratory syndrome in association with influenza vaccination, Can Commun Dis Rep, vol.28, issue.6, p.1, 2002.

D. Serres, G. Toth, E. Menard, S. Grenier, J. Roussel et al., Oculo-respiratory syndrome after influenza vaccination: trends over four influenza seasons, Vaccine, vol.23, issue.28, pp.3726-3758, 2005.
DOI : 10.1016/j.vaccine.2005.01.154

D. Skowronski, B. Strauss, D. Serres, G. Macdonald, D. Marion et al., Oculo???respiratory Syndrome: A New Influenza Vaccine???Associated Adverse Event?, Clinical Infectious Diseases, vol.36, issue.6, pp.705-718, 2003.
DOI : 10.1086/367667

K. Stratton, C. Howe, and R. Johnston, Adverse events associated with childhood vaccines: evidence bearing on causality, 1994.

M. Gold, J. Gidudu, M. Erlewyn-lajeunesse, and B. Law, Can the Brighton Collaboration case definitions be used to improve the quality of Adverse Event Following Immunization (AEFI) reporting?, Vaccine, vol.28, issue.28, pp.4487-98, 2010.
DOI : 10.1016/j.vaccine.2010.04.041

J. Steinke, T. Platts-mills, and S. Commins, The alpha-gal story: Lessons learned from connecting the dots, Journal of Allergy and Clinical Immunology, vol.135, issue.3, pp.589-96, 2015.
DOI : 10.1016/j.jaci.2014.12.1947

M. Pinson and K. Waibel, Safe administration of a gelatin-containing vaccine in an adult with galactose-alpha-1,3-galactose allergy, Vaccine, vol.33, issue.10, 2015.

J. Kelso, Allergic reactions after immunization, Annals of Allergy, Asthma & Immunology, vol.110, issue.6, pp.397-401, 2013.
DOI : 10.1016/j.anai.2013.03.001

. Anonymous, CDC: Possible side effects of vaccines. http://www.cdc.gov/ vaccines/vac-gen/side-effects.htm, 2016.

. Anonymous and . Who, Adverse Events Following Vaccines, 2016.

N. Halsey, The science of evaluation of adverse events associated with vaccination, Seminars in Pediatric Infectious Diseases, vol.13, issue.3, pp.205-219, 2002.
DOI : 10.1053/spid.2002.125864

N. Halsey, K. Edwards, C. Dekker, N. Klein, R. Baxter et al., Algorithm to assess causality after individual adverse events following immunizations, Vaccine, vol.30, issue.39, 2012.
DOI : 10.1016/j.vaccine.2012.04.005

A. Tozzi, E. Asturias, M. Balakrishnan, N. Halsey, B. Law et al., Assessment of causality of individual adverse events following immunization (AEFI): A WHO tool for global use, Vaccine, vol.31, issue.44, pp.5041-5047, 2013.
DOI : 10.1016/j.vaccine.2013.08.087

K. Stratton, A. Ford, E. Rusch, and E. Clayton, Adverse Effects of Vaccines: Evidence and Causality. Washington: The National Academies Press, 2011.

L. Jackson, O. Yu, J. Nelson, C. Dominguez, D. Peterson et al., Injection Site and Risk of Medically Attended Local Reactions to Acellular Pertussis Vaccine, PEDIATRICS, vol.127, issue.3, pp.581-588, 2011.
DOI : 10.1542/peds.2010-1886

M. Beveridge, I. Polcari, J. Burns, A. Adler, B. Hendrickson et al., Local Vaccine Site Reactions and Contact Allergy to Aluminum, Pediatric Dermatology, vol.62, issue.1, pp.68-72, 2012.
DOI : 10.1111/j.1525-1470.2011.01541.x

E. Bergfors and B. Trollfors, Sixty-four children with persistent itching nodules and contact allergy to aluminium after vaccination with aluminium-adsorbed vaccines???prognosis and outcome after booster vaccination, European Journal of Pediatrics, vol.15, issue.5???6, pp.171-178, 2013.
DOI : 10.1007/s00431-012-1841-2

L. Jackson, B. Carste, D. Malais, and J. Froeschle, Retrospective population-based assessment of medically attended injection site reactions, seizures, allergic responses and febrile episodes after acellular pertussis vaccine combined with diphtheria and tetanus toxoids, The Pediatric Infectious Disease Journal, vol.21, issue.8, pp.781-787, 2002.
DOI : 10.1097/00006454-200208000-00016

T. Nakayama, C. Aizawa, and H. Kuno-sakai, A clinical analysis of gelatin allergy and determination of its causal relationship to the previous administration of gelatin-containing acellular pertussis vaccine combined with diphtheria and tetanus toxoids, Journal of Allergy and Clinical Immunology, vol.103, issue.2, pp.321-326, 1999.
DOI : 10.1016/S0091-6749(99)70508-7

T. Nakayama and C. Aizawa, Change in gelatin content of vaccines associated with reduction in reports of allergic reactions, Journal of Allergy and Clinical Immunology, vol.106, issue.3, pp.591-592, 2000.
DOI : 10.1067/mai.2000.108433

V. Pool, M. Braun, J. Kelso, G. Mootrey, R. Chen et al., Prevalence of Anti-Gelatin IgE Antibodies in People With Anaphylaxis After Measles-Mumps-Rubella Vaccine in the United States, PEDIATRICS, vol.110, issue.6, p.71, 2002.
DOI : 10.1542/peds.110.6.e71

K. Jr, J. Cox, M. Reisinger, K. Hedrick, J. Graham et al., Evaluation of the safety, reactogenicity and immunogenicity of FluBlok trivalent recombinant baculovirus-expressed hemagglutinin influenza vaccine administered intramuscularly to healthy children aged 6?59 months, Vaccine, vol.27, issue.47, pp.6589-94, 2009.

I. Seqirus, Flucelvax package insert Holly Springs: Seqirus, Inc.; 2012, 2016.

M. Maglione, L. Das, L. Raaen, A. Smith, R. Chari et al., Safety of Vaccines Used for Routine Immunization of US Children: A Systematic Review, PEDIATRICS, vol.134, issue.2, pp.325-362, 2014.
DOI : 10.1542/peds.2014-1079

N. Halsey, M. Griffioen, S. Dreskin, C. Dekker, R. Wood et al., Immediate hypersensitivity reactions following monovalent 2009 pandemic influenza A (H1N1) vaccines: Reports to VAERS, Vaccine, vol.31, issue.51, pp.6107-6119, 2013.
DOI : 10.1016/j.vaccine.2013.09.066

A. Kawai, L. Li, M. Kulldorff, C. Vellozzi, E. Weintraub et al., Absence of associations between influenza vaccines and increased risks of seizures, Guillain-Barr?? syndrome, encephalitis, or anaphylaxis in the 2012-2013 season, Pharmacoepidemiology and Drug Safety, vol.381, issue.9876, pp.548-53, 2014.
DOI : 10.1002/pds.3575

A. Ropero-alvarez, A. Whittembury, P. Bravo-alcantara, H. Kurtis, M. Danovaro-holliday et al., Events supposedly attributable to vaccination or immunization during pandemic influenza A (H1N1) vaccination campaigns in Latin America and the Caribbean, Vaccine, vol.33, issue.1, pp.187-92, 2015.
DOI : 10.1016/j.vaccine.2014.10.070

R. Gagnon, M. Primeau, D. Roches, A. Lemire, C. Kagan et al., Safe vaccination of patients with egg allergy with an adjuvanted pandemic H1N1 vaccine, Journal of Allergy and Clinical Immunology, vol.126, issue.2, pp.317-340, 2010.
DOI : 10.1016/j.jaci.2010.05.037

J. Schuler, W. King, N. Dayneka, L. Rastelli, E. Marquis et al., Administration of the adjuvanted pH1N1 vaccine in egg-allergic children at high risk for influenza A/H1N1 disease, Can J Public Health, vol.102, issue.3, pp.196-205, 2011.

N. Vasu, G. Ghaffari, E. Craig, and T. Craig, Adverse events associated with intranasal influenza vaccine in the United States, Therapeutic Advances in Respiratory Disease, vol.2, issue.4, pp.193-201, 2008.
DOI : 10.1177/1753465808093933

M. Lee-wong, D. Resnick, and K. Chong, A generalized reaction to thimerosal from an influenza vaccine, Annals of Allergy, Asthma & Immunology, vol.94, issue.1, pp.90-94, 2005.
DOI : 10.1016/S1081-1206(10)61292-6

I. Rouleau, D. Serres, G. Drolet, J. Banerjee, D. Lemire et al., Allergic symptoms after pandemic influenza vaccination rarely mediated by vaccine-specific IgE, Journal of Allergy and Clinical Immunology, vol.130, issue.6, pp.1423-1429, 2012.
DOI : 10.1016/j.jaci.2012.07.019

. Anonymous, Statement on Seasonal Influenza Vaccine for 2015?2016 In: An Advisory Committee Statement (ACS) Publick Health Agency of Canada, 2015.

J. Carapetis, N. Curtis, and J. Royle, MMR immunisation, BMJ, vol.323, issue.7317, p.869, 2001.
DOI : 10.1136/bmj.323.7317.869a

H. Kuno-sakai and M. Kimura, Removal of gelatin from live vaccines and DTaP???an ultimate solution for vaccine-related gelatin allergy, Biologicals, vol.31, issue.4, pp.245-254, 2003.
DOI : 10.1016/S1045-1056(03)00063-0

D. Souza, R. Campbell-lloyd, S. Isaacs, D. Gold, M. Burgess et al., Adverse events following immunisation associated with the, 1998.

G. Bruno, P. Giampietro, M. Grandolfo, O. Milita, and L. Businco, Safety of measles immunisation in children with IgE-mediated egg allergy, The Lancet, vol.335, issue.8691, p.739, 1990.
DOI : 10.1016/0140-6736(90)90863-Z

G. Khakoo and G. Lack, Recommendations for using MMR vaccine in children allergic to eggs, BMJ, vol.320, issue.7239, pp.929-961, 2000.
DOI : 10.1136/bmj.320.7239.929

A. Esteghamati, A. Keshtkar, R. Heshmat, M. Gouya, S. Amoli et al., Adverse reactions following immunization with MMR vaccine in children at selected provinces of Iran, Arch Iran Med, vol.14, issue.2, pp.91-96, 2011.

D. Andersen and I. Jorgensen, MMR vaccination of children with egg allergy is safe, Dan Med J, vol.60, issue.2, p.4573, 2013.

F. Aviles, F. , C. Marti, M. , M. Gomez et al., Vacuna triple v??rica y alergia al huevo. Experiencia en una unidad de vacunaci??n hospitalaria, Anales de Pediatr??a, vol.67, issue.4, pp.362-369, 2007.
DOI : 10.1016/S1695-4033(07)70654-9

A. Patja, S. Makinen-kiljunen, I. Davidkin, M. Paunio, and H. Peltola, Allergic Reactions to Measles-Mumps-Rubella Vaccination, PEDIATRICS, vol.107, issue.2, p.27, 2001.
DOI : 10.1542/peds.107.2.e27

M. Fasano, R. Wood, S. Cooke, and H. Sampson, Egg hypersensitivity and adverse reactions to measles, mumps, and rubella vaccine, The Journal of Pediatrics, vol.120, issue.6, pp.878-81, 1992.
DOI : 10.1016/S0022-3476(05)81953-5

J. James, A. Burks, P. Roberson, and H. Sampson, Safe Administration of the Measles Vaccine to Children Allergic to Eggs, New England Journal of Medicine, vol.332, issue.19, pp.1262-1268, 1995.
DOI : 10.1056/NEJM199505113321904

J. Cronin, A. Scorr, S. Russell, S. Mccoy, S. Walsh et al., A review of a paediatric emergency department vaccination programme for patients at risk of allergy/anaphylaxis, Acta Paediatrica, vol.31, issue.3, 2012.
DOI : 10.1111/j.1651-2227.2012.02737.x

R. Sharrar, P. Larussa, S. Galea, S. Steinberg, A. Sweet et al., The postmarketing safety profile of varicella vaccine, Vaccine, vol.19, issue.7-8, pp.7-8916, 2000.
DOI : 10.1016/S0264-410X(00)00297-8

R. Wise, M. Salive, M. Braun, G. Mootrey, J. Seward et al., Postlicensure Safety Surveillance for Varicella Vaccine, JAMA, vol.284, issue.10, pp.1271-1280, 2000.
DOI : 10.1001/jama.284.10.1271

M. Sakaguchi, T. Yamanaka, K. Ikeda, Y. Sano, H. Fujita et al., IgE-mediated systemic reactions to gelatin included in the varicella vaccine????????????, Journal of Allergy and Clinical Immunology, vol.99, issue.2, pp.263-267, 1997.
DOI : 10.1016/S0091-6749(97)70108-8

M. Sakaguchi and S. Inouye, Systemic allergic reactions to gelatin included in vaccines as a stabilizer, Jpn J Infect Dis, vol.53, issue.5, pp.189-95, 2000.

T. Ozaki, N. Nishimura, T. Muto, K. Sugata, S. Kawabe et al., Safety and immunogenicity of gelatin-free varicella vaccine in epidemiological and serological studies in Japan, Vaccine, vol.23, issue.10, 2005.
DOI : 10.1016/j.vaccine.2004.08.040

I. Rabe, E. Miller, M. Fischer, and S. Hills, Adverse events following vaccination with an inactivated, Vero cell culture-derived Japanese encephalitis vaccine in the United States, 2009???2012, Vaccine, vol.33, issue.5, pp.708-720, 2009.
DOI : 10.1016/j.vaccine.2014.11.046

M. Bollinger, R. Hamilton, and R. Wood, Protamine allergy as a complication of insulin hypersensitivity: A case report?????????, Journal of Allergy and Clinical Immunology, vol.104, issue.2, pp.462-467, 1999.
DOI : 10.1016/S0091-6749(99)70394-5

R. Porsche and Z. Brenner, Allergy to protamine sulfate, Heart & Lung: The Journal of Acute and Critical Care, vol.28, issue.6, pp.418-446, 1999.
DOI : 10.1016/S0147-9563(99)70031-2

A. Dobardzic, H. Izurieta, E. Woo, J. Iskander, S. Shadomy et al., Safety review of the purified chick embryo cell rabies vaccine: Data from the Vaccine Adverse Event Reporting System (VAERS), 1997???2005, Vaccine, vol.25, issue.21, pp.4244-51, 1997.
DOI : 10.1016/j.vaccine.2007.02.075

H. Majchrowicz, Post-vaccination reactions to diploid rabies vaccine, Przegl Epidemiol, vol.43, issue.3, pp.259-62, 1989.

M. Haditsch and U. Kunze, Tick-borne encephalitis: A disease neglected by travel medicine, Travel Medicine and Infectious Disease, vol.11, issue.5, pp.295-300, 2013.
DOI : 10.1016/j.tmaid.2013.07.003

J. Suss, Tick-borne encephalitis 2010: Epidemiology, risk areas, and virus strains in Europe and Asia???An overview, Ticks and Tick-borne Diseases, vol.2, issue.1, 2011.
DOI : 10.1016/j.ttbdis.2010.10.007

P. Bogovic and F. Strle, Tick-borne encephalitis: A review of epidemiology, clinical characteristics, and management, World Journal of Clinical Cases, vol.3, issue.5, pp.430-471, 2015.
DOI : 10.12998/wjcc.v3.i5.430

O. Zent, J. Beran, W. Jilg, T. Mach, and A. Banzhoff, Clinical evaluation of a polygeline-free tick-borne encephalitis vaccine for adolescents and adults, Vaccine, vol.21, issue.7-8, pp.7-8738, 2003.
DOI : 10.1016/S0264-410X(02)00592-3

A. Loew-baselli, R. Konior, B. Pavlova, S. Fritsch, E. Poellabauer et al., Safety and immunogenicity of the modified adult tick-borne encephalitis vaccine FSME-IMMUN??: Results of two large phase 3 clinical studies, Vaccine, vol.24, issue.24, pp.5256-63, 2006.
DOI : 10.1016/j.vaccine.2006.03.061

E. Arroabarren, M. Anda, and M. Sanz, Anaphylaxis to pneumococcal vaccine; CRM(197): Novel cause of vaccine allergy, Pediatric Allergy and Immunology, vol.66, issue.4, pp.433-440, 2016.
DOI : 10.1111/pai.12548

M. Nelson, H. Oaks, L. Smith, and R. Engler, Anaphylaxis complicating routine childhood immunization: hemophilus influenza b conjugated vaccine. Pediatric Asthma, Allergy & Immunology, vol.14, issue.4, pp.315-336, 2000.

E. Chung, Vaccine allergies, Clinical and Experimental Vaccine Research, vol.3, issue.1, pp.50-57, 2014.
DOI : 10.7774/cevr.2014.3.1.50

T. Finn and W. Egan, Vaccine additives and manufacturing residuals in United States licensed vaccines Philadelphia: Saunders, pp.73-81, 2008.

. Anonymous, Allergens in Vaccines Institute for Vaccine Safety, Johns Hopkins Bloomberg School of Publick Health, 2015.

E. Bergfors, G. Hermansson, N. Kronander, U. Falk, L. Valter et al., How common are long-lasting, intensely itching vaccination granulomas and contact allergy to aluminium induced by currently used pediatric vaccines? A prospective cohort study, European Journal of Pediatrics, vol.15, issue.4, pp.1297-307, 2014.
DOI : 10.1007/s00431-014-2318-2

G. Lidholm, A. Bergfors, E. Inerot, A. Blomgren, U. Gillstedt et al., Unexpected loss of contact allergy to aluminium induced by vaccine, Contact Dermatitis, vol.131, issue.5, pp.286-92, 2013.
DOI : 10.1111/cod.12053

H. Chong, K. Brady, D. Metze, and E. Calonje, Persistent nodules at injection sites (aluminium granuloma)-clinicopathological study of 14 cases with a diverse range of histological reaction patterns, Histopathology, vol.15, issue.2, pp.182-190, 2006.
DOI : 10.1111/1523-1747.ep12496358

I. Rouleau, D. Serres, G. Drolet, J. Skowronski, D. Ouakki et al., Increased risk of anaphylaxis following administration of 2009 AS03-adjuvanted monovalent pandemic A/H1N1 (H1N1pdm09) vaccine, Vaccine, vol.31, issue.50, pp.5989-96, 2013.
DOI : 10.1016/j.vaccine.2013.10.033

I. Rouleau, D. Serres, G. Skowronski, D. Drolet, J. Lemire et al., Risk factors associated with anaphylaxis and other allergic-like events following receipt of 2009 monovalent AS03-adjuvanted pandemic influenza vaccine in Quebec, Canada, Vaccine, vol.32, issue.28, pp.3480-3487, 2014.
DOI : 10.1016/j.vaccine.2014.04.059

J. Stassijns, K. Bollaerts, M. Baay, and T. Verstraeten, A systematic review and meta-analysis on the safety of newly adjuvanted vaccines among children, Seqirus I. FLUAD, Package Insert, pp.714-736, 2016.
DOI : 10.1016/j.vaccine.2015.12.024

P. Fritsche, A. Helbling, and B. Ballmer-weber, Vaccine hypersensitivity?update and overview, Swiss Med Wkly, vol.140, pp.17-18238, 2010.

J. Leventhal, E. Berger, J. Brauer, and D. Cohen, Hypersensitivity Reactions to Vaccine Constituents, Dermatitis, vol.23, issue.3, pp.102-111, 2012.
DOI : 10.1097/DER.0b013e31825228cf

W. Zheng and S. Dreskin, THIMEROSAL IN INFLUENZA VACCINE: AN IMMEDIATE HYPERSENSITIVITY REACTION, Annals of Allergy, Asthma & Immunology, vol.99, issue.6, pp.574-579, 2007.
DOI : 10.1016/S1081-1206(10)60391-2

J. Lear and J. English, Anaphylaxis after hepatitis B vaccination, The Lancet, vol.345, issue.8959, p.1249, 1995.
DOI : 10.1016/S0140-6736(95)92039-0

M. Russell, V. Pool, J. Kelso, and V. Tomazic-jezic, Vaccination of persons allergic to latex: a review of safety data in the Vaccine Adverse Event Reporting System (VAERS), Vaccine, vol.23, issue.5, pp.664-671, 2004.
DOI : 10.1016/j.vaccine.2004.06.042

J. Hamborsky, A. Kroger, and C. Wolfe, Epidemiology and Prevention of Vaccine- Preventable Diseases. 13th ed. The Pink Book Public Health Foundation, Centers for Disease Control and Prevention Also, 2015.

J. Kelso, Safety of influenza vaccines, Current Opinion in Allergy and Clinical Immunology, vol.12, issue.4, pp.383-391, 2012.
DOI : 10.1097/ACI.0b013e328354395d

J. Kelso, J. Li, R. Nicklas, J. Blessing-moore, L. Cox et al., Adverse reactions to vaccines, Annals of Allergy, Asthma & Immunology, vol.103, issue.4, pp.1-14, 2009.
DOI : 10.1016/S1081-1206(10)60350-X

R. Wood, M. Berger, S. Dreskin, R. Setse, R. Engler et al., An Algorithm for Treatment of Patients With Hypersensitivity Reactions After Vaccines, PEDIATRICS, vol.122, issue.3, pp.771-778, 2008.
DOI : 10.1542/peds.2008-1002

J. Caubet, O. Rudzeviciene, E. Gomes, I. Terreehorst, K. Brockow et al., Managing a child with possible allergy to vaccine, Pediatric Allergy and Immunology, vol.23, issue.Suppl. 3, pp.394-403, 2014.
DOI : 10.1111/pai.12132

C. Ponvert, D. Ardelean-jaby, C. -. Gorski, A. Soufflet, B. Hamberger et al., Anaphylaxis to the 23-valent pneumococcal vaccine in child: a case-control study based on immediate responses in skin tests and specific IgE determination, Vaccine, vol.19, issue.32, pp.4588-91, 2001.
DOI : 10.1016/S0264-410X(01)00257-2

R. Wood, R. Setse, and N. Halsey, Irritant skin test reactions to common vaccines, Journal of Allergy and Clinical Immunology, vol.120, issue.2, pp.478-81, 2007.
DOI : 10.1016/j.jaci.2007.04.035

C. Ponvert, Les r??actions d???hypersensibilit?? allergique et non allergique aux vaccins contenant des anatoxines, Archives de P??diatrie, vol.16, issue.4, pp.391-396, 2009.
DOI : 10.1016/j.arcped.2009.01.002

L. Grohskopf, S. Olsen, L. Sokolow, J. Bresee, N. Cox et al., Prevention and Control of Seasonal Influenza with Vaccines, MMWR. Recommendations and Reports, vol.65, issue.5, pp.691-698, 2014.
DOI : 10.15585/mmwr.rr6505a1

J. Kelso, Raw egg allergy???A potential issue in vaccine allergy, Journal of Allergy and Clinical Immunology, vol.106, issue.5, p.990, 2000.
DOI : 10.1067/mai.2000.110800

I. Novartis, RabAvert package insert Basil: Novartis, Inc; 2013.Also, http:// www.fda.gov, 2016.

J. Herman, R. Radin, and R. Schneiderman, Allergic reactions to measles (rubeola) vaccine in patients hypersensitive to egg protein, The Journal of Pediatrics, vol.102, issue.2, pp.196-205, 1983.
DOI : 10.1016/S0022-3476(83)80519-8

O. Brien, T. Maloney, C. Tauraso, and N. , Quantitation of residual host protein in chicken embryo-derived vaccines by radial immunodiffusion, Appl Microbiol, vol.21, issue.4, pp.780-782, 1971.

J. Kelso, Administering influenza vaccine to egg-allergic persons, Expert Review of Vaccines, vol.13, issue.8, pp.1049-57, 2014.
DOI : 10.1586/14760584.2014.933079

D. Baxter, Measles immunization in children with a history of egg allergy, Vaccine, vol.14, issue.2, pp.131-135, 1996.
DOI : 10.1016/0264-410X(95)00154-S

H. Mclean, A. Fiebelkorn, J. Temte, G. Wallace, C. Centers-for-disease et al., Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP), MMWR Recomm Rep, vol.62, pp.1-34, 2013.

A. Fiore, T. Uyeki, K. Broder, L. Finelli, G. Euler et al., Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), MMWR Recomm Rep, vol.59, issue.8, pp.1-62, 2010.

G. Lee, S. Greene, E. Weintraub, J. Baggs, M. Kulldorff et al., H1N1 and Seasonal Influenza Vaccine Safety in the Vaccine Safety Datalink Project, American Journal of Preventive Medicine, vol.41, issue.2, pp.121-129, 2011.
DOI : 10.1016/j.amepre.2011.04.004

F. Tavares, A. Delaigle, D. Slavin, V. Bauchau, L. Fries et al., Anaphylaxis following H1N1 pandemic vaccines: Safety data in perspective, Vaccine, vol.29, issue.37, pp.6402-6409, 2011.
DOI : 10.1016/j.vaccine.2011.04.026

E. Woo, Allergic Reactions After Egg-Free Recombinant Influenza Vaccine: Reports to the US Vaccine Adverse Event Reporting System, Clinical Infectious Diseases, vol.60, issue.5, pp.777-80, 2015.
DOI : 10.1093/cid/ciu948

. Anonymous, European pharmacopia, 5.8 CD, 7 Euorpiean Directoriate for the Quality of Medicines and Health Care, 2007.

Z. Vajo, F. Tamas, and I. Jankovics, A Reduced-Dose Seasonal Trivalent Influenza Vaccine Is Safe and Immunogenic in Adult and Elderly Patients in a Randomized Controlled Trial, Clinical and Vaccine Immunology, vol.19, issue.3, pp.313-321, 2012.
DOI : 10.1128/CVI.05619-11

J. Kelso, M. Greenhawt, and J. Li, Joint Task Force on Practice P. Update on influenza vaccination of egg allergic patients, Ann Allergy Asthma Immunol, vol.111, issue.4, 2013.

D. Roches, A. Samaan, K. Graham, F. Lacombe-barrios, J. Paradis et al., Safe vaccination of patients with egg allergy by using live attenuated influenza vaccine, The Journal of Allergy and Clinical Immunology: In Practice, vol.3, issue.1, pp.138-147, 2015.
DOI : 10.1016/j.jaip.2014.08.008

P. Turner, J. Southern, N. Andrews, E. Miller, M. Erlewyn-lajeunesse et al., Safety of live attenuated influenza vaccine in young people with egg allergy: multicentre prospective cohort study, BMJ, vol.351, 2015.
DOI : 10.1136/bmj.h6291

P. Turner, J. Southern, N. Andrews, E. Miller, M. Erlewyn-lajeunesse et al., Safety of live attenuated influenza vaccine in atopic children with egg allergy, Journal of Allergy and Clinical Immunology, vol.136, issue.2, 1925.
DOI : 10.1016/j.jaci.2014.12.1925

L. Grohskopf, L. Sokolow, S. Olsen, J. Bresee, K. Broder et al., Prevention and Control of Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, Influenza Season. Centers for Disease Control and Prevention, pp.2015-2016, 2016.

. Sanofipasteur, . Yf-vax-package, and . Insert, Sanofi Pasteur Also, https://www.vaccineshoppe.com/image.cfm?doc_id=13709&image_ type=product_pdf, 2013.

J. Kelso, G. Cockrell, R. Helm, and A. Burks, Common allergens in avian meats??????????????????, Journal of Allergy and Clinical Immunology, vol.104, issue.1, pp.202-206, 1999.
DOI : 10.1016/S0091-6749(99)70136-3

J. Kelso, G. Mootrey, and T. Tsai, Anaphylaxis from yellow fever vaccine, Journal of Allergy and Clinical Immunology, vol.103, issue.4, pp.698-701, 1999.
DOI : 10.1016/S0091-6749(99)70245-9

R. Munoz-cano, J. Sanchez-lopez, J. Bartra, and A. Valero, Yellow fever vaccine and egg allergy: really a problem?, Allergy, vol.27, issue.4, pp.533-537, 2010.
DOI : 10.1111/j.1398-9995.2009.02205.x

K. Rutkowski, P. Ewan, and S. Nasser, Administration of Yellow Fever Vaccine in Patients with Egg Allergy, International Archives of Allergy and Immunology, vol.161, issue.3, pp.274-282, 2013.
DOI : 10.1159/000346350

M. Sakaguchi, T. Nakayama, and S. Inouye, Food allergy to gelatin in children with systemic immediate-type reactions, including anaphylaxis, to vaccines????????????, Journal of Allergy and Clinical Immunology, vol.98, issue.6, pp.1058-61, 1996.
DOI : 10.1016/S0091-6749(96)80191-6

Y. Sakai, R. Yamato, M. Onuma, T. Kikuta, M. Watanabe et al., Non-antigenic and Low Allergic Gelatin Produced by Specific Digestion with an Enzyme-Coupled Matrix., Biological & Pharmaceutical Bulletin, vol.21, issue.4, pp.330-334, 1998.
DOI : 10.1248/bpb.21.330

J. Bogdanovic, N. Halsey, R. Wood, and R. Hamilton, Bovine and porcine gelatin sensitivity in children sensitized to milk and meat, Journal of Allergy and Clinical Immunology, vol.124, issue.5, 2009.
DOI : 10.1016/j.jaci.2009.06.021

J. Kelso, R. Jones, and J. Yunginger, Anaphylaxis to measles, mumps, and rubella vaccine mediated by IgE to gelatin, Journal of Allergy and Clinical Immunology, vol.91, issue.4, pp.867-72, 1993.
DOI : 10.1016/0091-6749(93)90344-F

T. Kumagai, T. Yamanaka, Y. Wataya, A. Umetsu, N. Kawamura et al., Gelatin-specific humoral and cellular immune responses in children with immediate- and nonimmediate-type reactions to live measles, mumps, rubella, and varicella vaccines????????????, Journal of Allergy and Clinical Immunology, vol.100, issue.1, pp.130-134, 1997.
DOI : 10.1016/S0091-6749(97)70204-5

M. Sakaguchi, H. Ogura, and S. Inouye, IgE antibody to gelatin in children with immediate-type reactions to measles and mumps vaccines, Journal of Allergy and Clinical Immunology, vol.96, issue.4, pp.563-568, 1995.
DOI : 10.1016/S0091-6749(95)70304-7

S. Singer, C. Johnson, R. Mohr, and C. Holowecky, Urticaria following varicella vaccine associated with gelatin allergy, Vaccine, vol.17, issue.4, pp.327-336, 1999.
DOI : 10.1016/S0264-410X(98)00209-6

M. Sakaguchi, M. Yoshida, W. Kuroda, O. Harayama, Y. Matsunaga et al., Systemic immediate-type reactions to gelatin included in Japanese encephalitis vaccines, Vaccine, vol.15, issue.2, pp.121-123, 1997.
DOI : 10.1016/S0264-410X(96)00170-3

M. Worm, W. Sterry, and T. Zuberbier, Gelatin-induced Urticaria and Anaphylaxis after Tick-borne Encephalitis Vaccine, Acta Dermato-Venereologica, vol.80, issue.3, p.232, 2000.
DOI : 10.1080/000155500750043186

G. Nagel, R. Hennig, and M. Broker, New gelatine-free TBE vaccines with improved safety profile, Klin Padiatr, vol.218, issue.6, 2006.

T. Nakayama and C. Aizawa, Change in gelatin content of vaccines associated with reduction in reports of allergic reactions, Journal of Allergy and Clinical Immunology, vol.106, issue.3, pp.591-593, 2000.
DOI : 10.1067/mai.2000.108433

J. Kattan, G. Konstantinou, A. Cox, A. Nowak-wegrzyn, G. Gimenez et al., Anaphylaxis to diphtheria, tetanus, and pertussis vaccines among children with cow???s milk allergy, Journal of Allergy and Clinical Immunology, vol.128, issue.1, pp.215-223, 2011.
DOI : 10.1016/j.jaci.2011.04.046

C. Parisi, P. Smaldini, M. Gervasoni, J. Maspero, and G. Docena, Hypersensitivity reactions to the Sabin vaccine in children with cow's milk allergy, Clinical & Experimental Allergy, vol.40, issue.2 Suppl 2, pp.249-54, 2013.
DOI : 10.1111/cea.12059

J. Kelso, Potential food allergens in medications, Journal of Allergy and Clinical Immunology, vol.133, issue.6, pp.1509-1527, 2014.
DOI : 10.1016/j.jaci.2014.03.011

J. Slater, R. Rabin, and D. Martin, Comments on cow???s milk allergy and diphtheria, tetanus, and pertussis vaccines, Journal of Allergy and Clinical Immunology, vol.128, issue.2, 2011.
DOI : 10.1016/j.jaci.2011.06.028

S. Quirce and A. Diaz-perales, Diagnosis and Management of Grain-Induced Asthma, Allergy, Asthma & Immunology Research, vol.5, issue.6, pp.348-56, 2013.
DOI : 10.4168/aair.2013.5.6.348

X. Baur, P. Degens, and I. Sander, Baker???s asthma: Still among the most frequent occupational respiratory disorders????????????, Journal of Allergy and Clinical Immunology, vol.102, issue.6, pp.984-97, 1998.
DOI : 10.1016/S0091-6749(98)70337-9

J. Belchi-hernandez, A. Mora-gonzalez, and J. Iniesta-perez, Baker???s asthma caused by Saccharomyces cerevisiae in dry powder form, Journal of Allergy and Clinical Immunology, vol.97, issue.1, pp.131-135, 1996.
DOI : 10.1016/S0091-6749(96)70293-2

K. Airola, L. Petman, and S. Makinen-kiljunen, Clustered sensitivity to fungi: anaphylactic reactions caused by ingestive allergy to yeasts, Annals of Allergy, Asthma & Immunology, vol.97, issue.3, pp.294-301, 2006.
DOI : 10.1016/S1081-1206(10)60792-2

L. Bielory, A. Terr, N. Adkinson, B. Bochner, A. Burks et al., Unconventional Theories and Unproven Methods in Allergy Middleton's Allergy: Principles and Practice, pp.1616-1651, 2014.

&. Merck, . I. Co, . Recombivax-hb-package-insert, . Merck, . Inc et al., Also, https, 2014.

L. Dimiceli, V. Pool, J. Kelso, S. Shadomy, J. Iskander et al., Vaccination of yeast sensitive individuals: review of safety data in the US vaccine adverse event reporting system (VAERS), Vaccine, vol.24, issue.6, pp.703-710, 2006.
DOI : 10.1016/j.vaccine.2005.07.069

A. Atkinson, W. Wolfe, S. Hmborsky, and J. , Latex in Vaccine Packaging Epidemiology and Prevention of Vaccine-Preventable Diseases, 2012.

J. Yunginger, R. Jones, A. Fransway, J. Kelso, M. Warner et al., Extractable latex allergens and proteins in disposable medical gloves and other rubber products, Journal of Allergy and Clinical Immunology, vol.93, issue.5, pp.836-878, 1994.
DOI : 10.1016/0091-6749(94)90374-3

R. Hamilton, R. Brown, M. Veltri, E. Feroli, M. Primeau et al., Administering pharmaceuticals to latex-allergic patients from vials containing natural rubber latex closures, American Journal of Health-System Pharmacy, vol.62, issue.17, pp.1822-1829, 2005.
DOI : 10.2146/ajhp050021

R. Harbour and J. Miller, A new system for grading recommendations in evidence based guidelines, BMJ, vol.323, issue.7308, pp.334-340, 2001.
DOI : 10.1136/bmj.323.7308.334